| |
|
|
|
|
|
|
|||
|
Blood, Vol. 111, Issue 3, 1060-1066, February 1, 2008
Phase 1 study of the histone deacetylase inhibitor vorinostat (suberoylanilide hydroxamic acid [SAHA]) in patients with advanced leukemias and myelodysplastic syndromes Files in this Data Supplement:
| |||||||||||||||||||||||||||||
| Copyright © 2009 by American Society of Hematology Online ISSN: 1528-0020 | |||||||||